Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1411 to 1425 of 1598 results for nice quality standards or clinical guidelines

  1. Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs (TA445)

    Evidence-based recommendations on certolizumab pegol (Cimzia) and secukinumab (Cosentyx) for treating active psoriatic arthritis in adults.

  2. Delivering Rehabilitation EnAblement in CHronic Heart Failure (REACH-HF) in Wirral

    option for patients with heart failure and is covered by multiple NICE guidelines and Quality statements...

  3. Integrating service, audit and research data to improve patient care

    May 2017 NICE Quality Standard QS33 sets benchmarks for the management of rheumatoid arthritis (RA)

  4. The impact of Sherlock 3CG tip location and confirmation system (TCS) for PICC placement in our Radiology-based vascular access service.

    of staff shortages we had to review the service. Following publication of NICE MTG 24 in 2015 we undertook a successful evaluation of...

  5. Consultation on changes to technology appraisals and highly specialised technologies

    NICE and NHS England have launched a 12 week consultation on changes to the arrangements for evaluating and funding drugs and other health technologies appraised through NICE’s Technology Appraisal (TA) and Highly Specialised Technologies (HST) programmes.

  6. Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease (IPG677)

    Evidence-based recommendations on electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease. This involves delivering electrical impulses to weakened muscles using electrodes placed on the skin.

  7. Impact of pharmacist involvement in enhanced recovery pathways in improving patient care in those undergoing lower gastrointestinal surgery

    October 2016 Undertaken as a NICE scholar, the aim of this project was to demonstrate the impact of pharmacist

  8. Cannabidiol with clobazam for treating seizures associated with Dravet syndrome (TA614)

    Evidence-based recommendations on cannabidiol (Epidyolex) with clobazam for seizures associated with Dravet syndrome in people aged 2 years and older.

  9. Re-engineering the Post-Myocardial Infarction Medicines Optimisation Pathway

    Despite multiple NICE published guidance, quality standards, and technology appraisals, to reduce the burden...

  10. Sonata system for diagnostic imaging and treatment of symptomatic uterine fibroids (MIB255)

    NICE has developed a medtech innovation briefing (MIB) on the Sonata system for diagnostic imaging and treatment of symptomatic uterine fibroids .

  11. Diagnostic technologies stakeholder registration

    who is one of the following: The company that notified the technology to NICE, and sponsors or manufacturers of related technologies. A...

  12. Blackburn with Darwen Integrated Wellbeing Service

    issues as well as picking up the wider determinants of health. We used NICE Guideline PH6 Behaviour change: general...

  13. Sorafenib for treating advanced hepatocellular carcinoma (TA474)

    Evidence-based recommendations on sorafenib (Nexavar) for treating advanced hepatocellular carcinoma in adults.

  14. Developing and communicating effective pathways for patients with sarcoma in London and South East England

    created to publish and increase awareness of the pathways and supporting guidelines, including information on site-specific sarcomas....

  15. Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years (TA213)

    Evidence-based recommendations on aripiprazole for treating schizophrenia in young people aged 15 to 17.